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The macrophage has been implicated in the elaboration of a spectrum of 
molecules which alter  or modulate the functions  of  hemopoietic and lymphoid 
cells.  These include colony-stimulating  factor  (CSF),'  required for  the renewal 
and clonal  proliferation  of  granulocyte-macrophage stem cells  in semisolid  cul- 
ture (1),  lymphocyte-activating factor  which potentiates  the mitogenic response 
of  T lymphocytes to lectin  and histocompatibility  antigen (2-4),  as well  as fac- 
tors  which increase  the helper function  of  T lymphocytes (5, 6) and the promo- 
tion  of  soluble  mediator production by lymphocytes (7-9).  The role  of  the macro- 
phage in the regulation of humoral immune responses is however, less  well 
understood. In contrast to the reported  potentiation  by cell-free  macrophage 
supernates of  B-cell  differentiation  into  antibody-secreting  cells  in response to 
sheep erythrocytes (SRBC) and hapten-protein conjugates (10, 11),  mitogen- 
induced B-lymphocyte proliferative  responses are suppressed in the presence of 
macrophages (12-15). 
We have elected  to investigate  the immunoregulatory role  of  the macrophage 
in B-cell  activation  by utilizing  a two-layer semisolid culture system which 
prevents macrophage-lymphocyte,  as well  as lymphocyte-lymphocyte contact, 
and in which  only diffusible interactions may  occur. In this system,  the 
capacity  of  a B lymphocyte to undergo focal  proliferation  and generate a clone 
or colony is taken as the immunological  end point of B-cell activation, a 
process  dependent upon 2-mercaptoethanol (16)  and mitogens native to labora- 
tory-grade agar (17).  As previously reported, this  functional population of 
clonable B lymphocytes, the majority of  which bear Fc receptors,  IgM, and la 
antigens on their  surface (18,  19),  are heterogeneous  with respect  to size  and 
density and are widely distributed  in lymphoid tissues  (20,  21). 
We report  here that B-cell  activation  under these conditions is dependent 
upon diffusible  factor(s)  elaborated by macrophages. In addition,  the ability  of 
* Supported  by  grants  CA-17085,  CA-19052,  and  A1-12741  from  The  National  Institutes  of 
Health. 
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' Abbreviations  used  in this paper:  AM, agar-derived mitogen; CSF, colony-stimulating factor; 
Con  A,  eoncanavalin  A;  DS,  dextran  sulfate;  FCS,  fetal  calf  serum;  ['2~I]IUDR, 
['25I]iododeoxyuridine; LPS,  lipopolysaecharide; 2-ME, 2-mercaptoethanol;  PEC, peritoneal exu- 
date cells; PGE, E-series prostaglandins; SRBC, sheep erythrocytes. 
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indomethacin  to  prevent  suppression  of B-cell  activation  as  a  result  of an 
accumulation of macrophage-derived factor(s), indicates a role for prostaglan- 
din, and suggests that the dual regulatory influence that macrophages exert on 
B-cell activation operates via the elaboration of individual molecules. Prelimi- 
nary evidence is presented that immunomodulating agents such as lipopolysac- 
charide may alter the production of these B-lymphocyte regulatory factors by 
macrophages. 
Materials and Methods 
Animals.  Female B6D2F1  mice (Cumberland View Farms,  Clinton, Tenn.) were used at 2-3 
mo of age and provided spleen and lymph nodes, as well as peritoneal macrophages. Macrophages 
for some experiments were also obtained from C57BL/6 mice (Jackson Laboratories, Bar Harbor, 
Maine)  and  CBA/Cum mice  (Cumberland  View Farms)  of either  sex.  Neonatal  spleens  were 
harvested from two litters of CBA/Cum mice less than 24 h after birth. 
Preparation of Cell Suspensions.  Spleen and axillary, mesenteric and subcutaneous abdomi- 
nal  lymph  nodes  were  sterilely  excised,  sliced  into  1-mm  fragments  and  teased  through  a 
stainless steel mesh.  Large fragments of connective tissue and fat were removed and the cells 
washed three  times,  counted,  appropriately  diluted,  and  kept on ice until needed.  Stimulated 
peritoneal exudates were induced by intraperitoneal injections of 1.5  ml thiogiycollate medium 
(Difco Laboratories,  Detroit,  Mich.).  4 days  later,  the mice were killed by cervical dislocation 
their  abdominal  skin  reflected,  8  ml  of  ice-cold  serum-free  McCoy's  5A  Modified  Medium 
containing 5 U  of heparin/ml injected i.p., and the peritoneal contents were gently agitated and 
withdrawn  into a  syringe fitted with  an  18-gauge needle.  The peritoneal  exudate  cells  (PEC) 
were washed twice at 4°C, suspended  in ice-cold serum-free medium, the number of nucleated 
cells counted,  and appropriately diluted. This procedure yielded 30-50  ×  106 PEC per mouse of 
which 75% was morphologically typical macrophages.  Noninduced resident peritoneal cells were 
harvested by sterilely washing out the peritoneal cavity with 8 ml of ice-cold serum-free medium. 
Adherent  Cell Depletion  by  Sephadex  G-IO Columns.  The  preparation  of  adherent  cell- 
depleted mouse spleen or lymph node cell suspensions by passage through columns of Sephadex 
G-10,  was based upon the technique of Ly and Mischell (22).  2 ml of 1  ×  108 washed spleen or 
lymph node cells/ml in McCoy's 5A Modified Medium containing 5% fetal calf serum (FCS; Flow 
Laboratories,  Inc., Rockville, Md.) was gently pipetted into 10-ml syringes containing 10 ml of 
autoclaved and washed Sephadex G-10 beads  (Pharmacia Fine Chemicals, Inc., Piscataway,  N. 
J.) which was warmed to 40°C. After disappearance of the cell suspension beneath the surface of 
the  Sephadex,  5  ml  of Hanks'  balanced  salt  solution  containing  5%  FCS was  added  and  the 
nonadherent filtrate cells sterilely collected, washed three times, and counted. Cells recovered in 
the  column  filtrate  constituted  30-40%  of the  initial  unseparated  spleen  or  lymph  node  cell 
suspension.  Determination  of residual macrophages  in the adherent cell-depleted  lymphoid 
suspensions was performed by staining  with neutral red (23)  the  cells  immediately after  depletion 
or those cells  remaining adherent to plastic  culture dishes after 4-5 days of incubation. The 
extremely low incidence of  macrophages seen after  the short in  vitro  culture period excluded the 
presence of  nonadherent macrophage precursors. 
Separation of Phagocytic Cells by Carbonyl Iron Ingestion.  1  x  107 mouse spleen cells were 
incubated  in 3.0 ml McCoy's 5A Modified Medium containing 10% FCS and 250 mg of dry-heat 
sterilized carbonyl iron (Atomergic Chemetals Corp., Plainview, N. Y.) in sterile glass Leighton 
tubes.  After incubation  at 37°C  for 45  min with gentle agitation every 5 min,  the tubes were 
placed flat-side down on a  large magnet and the contents were carefully eluted.  2 ml of fresh 
medium was added to the tubes,  the process repeated,  and the contents were pooled with the 
previous  cells.  These  cells were  placed  into  clean  Leighton  tubes  and  again  situated  on  the 
magnet  to remove residual  iron-containing  cells.  After this procedure,  the  cells were washed 
three  times  in  McCoy's medium  containing  15%  FCS  and  appropriately  diluted.  Spleen  cells 
prepared in this manner,  though constituting only 40-50% of the original cell suspension,  were 
devoid of macrophages as determined by neutral red staining. 
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earlier  (24).  Briefly,  various numbers of adult mouse spleen,  lymph node,  or  neonatal spleen 
cells were cultured in 0.3% Bacto-agar in McCoy's 5A Modified Medium containing 15% FCS and 
supplemented with additional essential and nonessential amino acids,  glutamine,  asparagine, 
and sodium pyruvate.  2-Mercaptoethano] (2-ME) was incorporated into the agar-cel] medium at 
a  final concentration of 5  ×  10  -5 M  and 1 m] of the agar-cell mixture dispensed in 35-mm Petri 
dishes  (Lux  Scientific Corp.,  Newbury  Park,  Calif.)  and allowed to  gel.  Colonies  were  scored 
after 5-7 days of incubation at 37°C  in a  humidified atmosphere of 10%  CO2  in air,  using an 
Olympus dissecting microscope (Olympus Corporation of America, New Hyde Park, N. Y.) at 25 
times magnification. In particular experiments, 20 fzg lipopolysaccharide (LPS) from Salmonella 
typhosa (W0901, Difco Laboratories) or 0.05 ml of a  10% vol/vo] washed SRBC suspension (Grand 
Island Biological Co., Grand Island, N. Y.) were included in the soft agar cultures. 
The effects of diffusible factors elaborated by an adherent population of peritoneal macrophages 
on  B-lymphocyte  colony  formation was  investigated in  a  two-layer  soft  agar  culture  system 
which consisted of a  1-ml 0.3% agar matrix containing spleen or lymph node cells suspended over 
underlayers of adherent macrophages. Various numbers of either thiog]ycollate-induced PEC or 
noninduced peritoneal washout cells were allowed to adhere to 35-ram Petri dishes in McCoy's 
medium  containing  15%  FCS.  After  1.5  h  at  37°C,  the  nonadherent  cells  of  the  exudate 
(comprising mostly lymphocytes and polymorphonuclear leukocytes) were vigorously washed off. 
To the peritoneal macrophages remaining adherent to the culture dishes was added a  1-ml cell- 
free 0.5% agar layer in complete McCoy's medium.  The 0.5% agar layer constituted a  physical 
separation between the adherent macrophages and the overlying layer of spleen or lymph node 
cells suspended in I  m] of 0.3% soft agar medium.  Control underlayers containing only cell-free 
0.5% agar in McCoy's medium (i.e., no macrophages) were prepared at the same time and were 
used to control for the additional nutrients provided by the extra culture medium. Indomethacin 
(Sigma Chemical Co., St.  Louis, Mo.), a  known inhibitor of prostaglandin synthesis, was added 
to both control and adherent macrophage underlayers. 
The adherent components of thioglycollate-induced PEC consisted mainly of macrophages as 
determined by their ability to stain with the vital lysosomal stain, neutral red,  and comprised 
20-30% of the initial exudato population. Noninduced peritoneal adherent macrophages comprised 
10-15% of the initial peritoneal washout population. 
Preparation of Macrophage-Conditioned Medium.  To the various numbers of adherent perito- 
neal macrophages was added 1 ml of McCoy's medium containing 15% FCS and 5 x  10  -5 M 2-ME 
in the  absence and presence  of LPS,  SRBC,  and indomethacin.  The supernatant media  were 
harvested 48 h  later, centrifuged at 5,000 rpm for 15 rain, Millipore filtered (a 0.45-~tm pore size, 
Millipore Corp.,  Bedford,  Mass.),  and assayed for B-lymphocyte colony-stimulating activity at 
various volume  percents in cultures  of either unseparated or Sevhadex G-10 passaged  lymph 
node cells. 
Conventional Mitogen-Stimulated Lymphocyte Culture.  Sephadex G-10 column-purified lymph 
node cells were cultured in the absence and presence of varying numbers of adherent peritoneal 
macrophages  and  tested  for  their  responsiveness  to  a  number of mitogens.  Briefly,  various 
numbers  of  thioglycollate-induced  PEC  were  allowed  to  adhere  in  Microtest  wells  (Falcon 
Plastics, Div. of BioQuest, Oxnard, California) for 1.5 h  and the nonadherent cells removed. The 
adherent macrophages were vigorously washed and 0.2 ml of 2  x  106 or 2.5  x  10  s Sephadex G-10- 
passaged lymph node cells/ml in McCoy's 5A Modified Medium containing 15% FCS was added 
per well.  Mitogens used for stimulating these lymphocyte cultures were LPS from S. typhosa, 5 
gg/culture; dextran sulfate (DS; 5 x  104 mol wt, Pharmacia Fine Chemicals, Inc.), 20 mg culture; 
concanavalin  A  (Con  A;  Pharmacia  Fine  Chemicals,  Inc.),  5  gg/culture;  and  agar-derived 
mitogens  (AM)  prepared  as  previously  described  (17),  25  gg/culture.  Cultures  were  initiated 
either  with  or  without  FCS  to  investigate  serum-dependence  of  mitogenesis.  After  72  h  of 
incubation at 37°C in 7% CO~ in humidified air, 0.2/xCi [l=I]iododeoxyuridine ([~2sI]IUDR;  sp act 
200  Ci/mM,  New  England  Nuclear,  Boston,  Mass.)  was  added  to  the  culture  wells  for  an 
additional 3 h. The cells were harvested by a  semi-automatic cell harvester, deposited on filter 
paper, washed with saline and 10% trichloroacetic acid (TCA), and the incorporation of [~2sI]IUDR 
counted in a  gamma counter, as previously described (17). 
Results 
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Macrophage Requirement for B-Lymphocyte Colony Formation by CBA/Cum Adult 
Spleen, Lymph Node, and Neonatal Spleen Cells* 
Number  Neonatal 
of  PEC  Adult  spleen  Adult  lymph node  spleen 
used  as 
Sephadex  Unsepa-  Sephadex  Carbonyl  Unsepa-  G-10  sep-  source  of  Unsepa- G-10  sep- iron  sepa- 
adherent  rated  rated  rated 
MO$  arated  1"ated  arated 
None  310  ±  21  120  ±  17  98  ±  4  31  ±  2  4  ±  1  0 
5  x  l0  s  288  ±  18  221  -+  20  187  ±  12  68  ±  1  64_+  4  32  ±  4 
1  x  104  316  ±  18  310  ±  18  325  ±  18  164  ±  8  169  ±  6  81  ±  6 
5  x  104  295  ±  12  420  ±  18  405  ±  13  258  ±  13  286  ±  6  118  ±  10 
1  x  10  s  240  ±  17  364  ±  21  372  ±  11  213  ±  16  266  ±  14  133  ±  8 
5  x  l0  s  148  ±  17  230  ±  17  232  ±  6  147  ±  8  162  ±  12  36  ±  7 
* 5 x los  nucleated cells  per culture. 
* PEC harvested 4 days post-intraperitoneal  injection  of thioglycollate  medium in CBA/Cum 
mice. 
quirement for macrophages  in B-cell colony formation and the ability  of our 
two-layer culture system to satisfy this requirement was initially  tested by 
using  B  lymphocytes  from  various tissue sources  (Table  I). B-lymphocyte 
colony formation by  neonatal spleen and adult lymph node cells  was consistently 
and markedly potentiated by  culture underlayers containing an optimal number 
of  peritoneal macrophages. Similar numbers of  macrophages only occasionally 
increased numbers of  colonies developing in cultures of  adult spleen, though in 
most cases,  the presence of  macrophages markedly increased mean colony size. 
When suspensions of  adult spleen or lymph node were depleted of  phagocytic or 
adherent cells  by carbonyl iron or passage over Sephadex G-10, respectively, 
the incidence of  colony-forming cells  was significantly  decreased. Colony num- 
ber was restored to normal or supranormal levels,  however, when macrophage- 
depleted suspensions were cultured over  underlayers containing various concen- 
trations of  macrophages. 
These observations indicate that macrophages are required for B-cell  colony 
formation and that this  requirement can be satisfied  by diffusible  macrophage- 
derived  factors. Newborn  spleens, and  to a  lesser extent, adult  spleens, 
contained  appreciable  numbers  of granulocyte-rnacrophage  progenitor  cells 
which  underwent  clonal proliferation in the presence of CSF  produced  by 
macrophages in the underlayers. Such myeloid colonies were, however, distin- 
guished from B-lymphocyte colonies  by their  gross morphology, lack of  sensitiv- 
ity to anti-Ig, and by conventional histochemical differentiation  of the cells 
comprising the colonies. Macrophage-depleted  lymph node cells  contained no 
granulocyte-macrophage  progenitor cells  which could respond to macrophage- 
derived CSF, and as a practical  matter we therefore employed lymph node cells 
as targets  for macrophage  regulation  in all subsequent  studies of B-cell 
activation. 
Role of  Macrophage-Derived Prostaglandin in the Inhibition of  B-Lymphocyte 
Clonal Proliferation.  As shown in Table II, increasing the numbers of macro- 
phages in culture underlayers invariably depressed colony formation. We have 1424  B-CELL  REGULATION  BY  MACROPHAGE  FACTORS 
TABLe.  II 
Effect of Combinations  of Peritoneal Macrophages, 
Lipopolysaccharide,  and SRBC on the Frequency of B- 
Lymphocyte  Colony Formation 
Number B-lymphocyte colo- 
Addition*  nies per 7.5 ×  104 lymph node 
cells +  SEM 
None*  0  _+  0 
MO$  109  _+  9 
LPS§  72  _+  3 
SRBql  35  _+ 2 
MO  +  LPS  247_+  6 
MO  +  SRBC  193  _+  11 
LPS  +  SRBC  212  _+  15 
MO  +  LPS  +  SRBC  311  _+  19 
* Cell-free 0.5% agar culture underlayer. 
Adherent  macrophages  from  1  ×  105  thioglycollate-induced  PEC 
incorporated  in culture underlayer. 
§ 2O ~g LPS. 
[I 0.1 ml of 10% washed SRBC. 
previously reported that B-lymphocyte colony formation by adult spleen cells 
can be effectively inhibited by concentrations of prostaglandin E  (PGE,  and 
PGE2) as low as 10-1°-10  -'2  M  (24), and that macrophages represent a  major 
source of PGE within the hemopoietic system (25, 26). We therefore tested the 
effect of the  prostaglandin  synthetase inhibitor,  indomethacin (27), on  the 
diminution of B-lymphocyte colonies observed in cultures containing an exces- 
sive number of macrophages (Fig.  1). Cultures of lymph node cells depleted of 
adherent  cells  by  prior  passage  through  Sephadex  G-10 formed  very  few 
colonies.  Colony number was increased ----  14-fold by an optimal number (0.05 × 
106) of peritoneal macrophages, whereas an excess of macrophages significantly 
suppressed colony formation.  Note  that in  the presence of adherent macro- 
phages  derived from  1  ×  106  PEC,  <10%  of the  clonable B-cell  population 
commenced proliferation to form colonies.  However, the inclusion of indometh- 
acin into the cultures permitted a  clonal efficiency identical to that observed 
under peak control conditions. Indomethacin had no effect on B-lymphocyte 
colony formation in the absence of peritoneal macrophages, thus indicating a 
role for macrophage-derived prostaglandin in the suppression of B-cell  clonal 
proliferation. Note that at macrophage concentrations of 1 ×  10  ~ and greater, 
the effectiveness of indomethacin to prevent inhibition decreased, suggesting 
that the accumulation of other macrophage products, in addition to prostaglan- 
din, may be involved in the suppression of B-cell proliferation. 
Comparison of Macrophage-Containing Underlayers with Other Potentiators 
of B-Cell Colony Formation.  The B-cell colony assay as originally described 
(20) is characteristically nonlinear; i.e., colony number is not a linear function 
of the  number  of B  cells  placed  in  culture.  Colony  formation  is  mitogen 
dependent (17) and the addition of the B-cell mitogen LPS, or SRBC enhances 
colony formation, particularly when few B cells are cultured (20). We therefore 
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Fro.  1.  Effect  of indomethacin on the  inhibition of B-lymphocyte colony  formation by 
high numbers of peritoneal macrophages.  1  x  10  ~ Sephadex G-10-passaged B6D2F1 lymph 
node cells/ml were cultured over agar underlayers containing adherent macrophages from 
various numbers of B6D2F1 thioglycollate-induced PEC.  Macrophage-containing and cell- 
free underlayers were prepared in the absence (control) and presence of indomethacin 24 h 
before the addition of the lymph node cells. 
agents.  Based  on  the  observations described  in  Fig.  1,  1  x  10  5 peritoneal 
macrophages and 1.4  ×  10  -z indomethacin, were selected as conditions which 
ensure sufficient macrophage-derived B-cell  stimulating factor(s) and prevent 
prostaglandin-mediated suppression.  Both macrophage underlayers and LPS 
resulted in linear dose-response curves (Fig.  2), which were calculated statisti- 
cally by linear regression analysis to possess r ~ of 1.0, and have nearly equal 
slopes.  Analysis of SRBC-stimulated colony formation also  demonstrated a 
linear dose-response (r  2 =  1.0), but the slope of this relationship was signifi- 
cantly greater than that of macrophage- or LPS-stimulated cultures. At any 
given concentration of lymph node cells cultured under the varied conditions, 
different numbers of colonies resulted. 
To determine if these potentiating agents act via a  common mechanism to 
augment colony formation by the same or different lymphocyte subpopulation, 
we  prepared  lymph node  cell  cultures  in  the  absence  and  presence of all 
possible combinations of these agents (Table II).  Greater numbers of colonies 
were obtained in cultures containing two or more of these potentiating agents 
than with  any one  alone.  When all  three potentiators were used together, 
-13%  of the  B  cells proliferated sufficiently to  form colonies and  a  larger 
number formed clusters (not shown). The observed increase in colony formation 
in the co-presence of the potentiating agents was slightly greater than additive, 
suggesting that each may only induce a particular subpopulation of B cells to 
undergo clonal proliferation. Alternatively, LPS and SRBC may have an effect 
on augmenting the elaboration of stimulatory factors by those macrophages 
present in the lymph node suspension or in the culture underlayer. 
Requirement for Macrophages in Mitogen-Stimulated  Liquid Cultures.  We 
tested the ability of macrophages to potentiate or inhibit B-cell proliferation in 
conventional liquid cultures of mitogen-stimulated lymphocytes. 4 ×  105 Seph- 1426  B-CELL  REGULATION  BY  MACROPHAGE  FACTORS 
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FIG.  2.  Comparative potentiation of lymph node B-lymphocyte colony-forming ability by 
peritoneal macrophages (MO), endotexin, and SRBC. Various numbers of B6D2F1 lymph 
node cells were cultured in soft agar medium over cell-free or 1 x  10  5 peritoneal exudate 
macrophage-containing underlayers in the presence of 1.4  x  10  -~ M indomethacin. SRBC, 
LPS, or phosphate-buffered saline (PBS) were included in cultures prepared over cell-free 
underlayers. 
adex G-10-passaged lymph node cells were added to  culture wells to  which 
different numbers of  peritoneal macrophages were previously allowed to adhere. 
Significant proliferative responses, (as assayed by [125I]IUDR incorporation on 
day 3) to the B-cell mitogens, DS, LPS, and AM, and the T-cell mitogen Con A, 
were observed in cultures initiated in the absence of additional macrophages 
(Fig.  3A).  Stimulation with DS was variable and occasionally augmented by 
macrophages, and optimal responsiveness to Con A always occurred when low 
numbers of macrophages were present. When the ratio of initially added PEC 
to  lymph node  cells exceeded 1:10, marked inhibition  of all  responses was 
observed. Essentially the same results were obtained in serum-free cultures, 
except that no lymphocyte stimulation was observed with the serum-dependent 
mitogen, Con A (Fig.  3B). 
These observations are consistent with previously reported findings (12-15) 
and were obtained using relatively high initial cell densities. Since we were 
unable to demonstrate macrophage potentiation of B-cell responses to LPS and 
AM in these cultures, and other studies suggest that the lymphocytes which 
respond in high density liquid culture and semisolid culture are different (26), 
we tested the effects of macrophages on liquid cultures prepared at relatively 
low cell densities; i.e., conditions more nearly approximating those which occur 
in the semisolid cultures. An eightfold reduction in the number of lymphocytes 
cultured reduced the magnitude of the responses, but the effect of macrophages 
was not significantly different (not shown).  That is,  no potentiation of the 
responses was observed and an excess of macrophages completely prevented 
lymphocyte  stimulation. In other experiments, the inhibition of B-cell responses 
to mitogens in liquid cultures by macrophages was not reversible with indo- 
methacin (not shown). In contrast to the dramatic potentiation of B-cell clonal 
proliferation in  semisolid cultures by macrophage-derived factors,  we  were 301 
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FIG.  3.  Effect of  various numbers of  adherent macrophages on the mitogen-responsiveness 
of macrophage-depleted lymph node cells in liquid cultures performed in serum-containing 
(A)  or serum-free (B)  medium.  Proliferative responses  were  assessed  by  the  amount  of 
[I~sI]IUDR incorporation (counts per minute) after 72 h of  culture, as described in Materials 
and Methods. 
unable to demonstrate this activity in conventional liquid cultures.  Further- 
more, since indomethacin did not prevent high dose macrophage inhibition in 
liquid cultures, macrophages may be able to suppress B-cell activation through 
a contact-mediated mechanism, independent of prostaglandin. Thus, the semi- 
solid culture system is uniquely suited to detecting both macrophage-derived 
stimulating and inhibiting principles. 
Detection of B-Lymphocyte Colony-Stimulating Activity in Peritoneal Macro- 
phage-Conditioned Medium.  Since the stimulatory and inhibitory actions of 
adherent macrophages on the clonal proliferation of B lymphocytes in semisolid 
culture involve the elaboration of factors which can diffuse through an agar 
layer separating the macrophages from the responding B cells, we attempted 
to obtain a  cell-free conditioned medium which could exhibit these activities. 
48-h  conditioned medium from  1  ×  105  thioglycollate-induced macrophages 
exhibited  appreciable  B-cell  colony-stimulating activity  at  25%  vol/vol,  but 
colony numbers declined at higher concentrations (Fig. 4). In contrast, medium 
conditioned by  noninduced macrophages was  significantly more effective in 
stimulating B-lymphocyte clonal proliferation and no decline in colony numbers 
was  observed  at  correspondingly high  concentrations.  Thus,  in  the  case  of 
thioglycollate-induced  macrophages, both stimulatory and inhibitory principles 
were detectable in conditioned medium. 
Effect  of LPS  and  SRBC  on  Macrophage  Production  of B-Lymphocyte 
Colony-Stimulating  Activity.  Since  both  LPS  and  SRBC  potentiate  B-cell 
clonal proliferation  (Fig.  2)  we investigated whether this effect may in part 
reflect an action on the elaboration of stimulatory factors from macrophages. 
Conditioned media from 1 ×  l0  S thioglycollate-induced macrophages prepared 
in  the presence and absence of LPS or SRBC  were assayed for stimulating 
activity in cultures of Sephadex G-10-passaged lymph node cells, as before. To 1428  B-CELL  REGULATION  BY  MACROPHAGE  FACTORS 
200 
.?.,, 
o  ~  150 
~  IO0 
5o 
L 
[]  THIOGLYC. INDUCED Me 
[]  NONINDUCED MO  i 
0%  10% 25% 50%  10% 25% 50% 
PERCENT VOI/VOI  MEDIUM 
CONDITIONED BY  5xlO 5  MID 
FIG.  4.  Effect  of thioglycollate-induced  and  noninduced  peritoneal  macrophage-condi- 
tioned medium  on lymph node  B-lymphocyte  colony formation.  48-h conditioned media 
from  the  adherent  macrophages  (MO)  of  5  ×  105  B6D2F1  thioglycoUate-induced  and 
noninduced PEC were incorporated in soft agar cultures of 5 x  104 B6D2F~ lymph node cells. 
control for the direct stimulatory actions of LPS, 20 ~g of LPS was incubated 
for 48 h  in macrophage-free medium (LPS medium). All concentrations of the 
different supernates possessed demonstrable but varying levels of B-lymphocyte 
stimulatory activity (Fig. 5). Macrophage-conditioned medium prepared in the 
presence  of LPS  potentiated colony formation to  the  extent that  would be 
predicted from  the  independent effects  of LPS  and  macrophage  supernate 
alone.  However,  when  higher  concentrations  of conditioned medium were 
tested, it was apparent that the supernate generated in the presence of both 
macrophages and LPS contained significant quantities of inhibitory activity. 
Therefore, the net effect of LPS was to augment inhibitor production by the 
macrophages.  Medium conditioned by  SRBC  alone  had  no  effect  on  B-cell 
colony formation (not shown). However, macrophage-conditioned medium pre- 
pared  in the presence of SRBC  had more enhancing activity than medium 
conditioned by macrophages alone. 
Therefore, both LPS and SRBC can modulate the production of immunoregu- 
latory  substances by macrophages. Under the conditions employed in these 
experiments,  LPS augmented inhibitor production and  SRBC  enhanced the 
release  of B-cell potentiating factors by macrophages. In other experiments 
(not shown), indomethacin largely prevented the pronounced suppressor activ- 
ity  of high  numbers  of LPS-treated  macrophages.  This  protective  effect of 
indomethacin was independent of a direct action on the B-lymphocyte, but was 
active  only  when  continuously present  during  conditioning of medium by 
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Effect  of  endotoxin and SRBC on peritoneal  macrophage (MO) production of  B- 
lymphocyte colony-stimulating factor.  Various volume percents of 48-h conditioned me- 
dia of 1 x  10  ~ B6D2F~ thioglycollate-induced  peritoneal macrophages prepared in the 
absence and presence of  20 ~g LPS and 0.05  ml of  10% SRBC were incorporated into  soft 
agar cultures  of  I x 105 Sephadex G-10-passaged B6D2F] lymph node cells.  Macrophage- 
free  medium containing only LPS and incubated for 48 h, served to control  for  the direct 
stimulatory effects  of  LPS. 
Discussion 
The results reported here indicate that low cell density semisolid cultures 
are ideally suited to studying the role of macrophages in mitegen activation of 
B lymphocytes in vitro. Very few proliferating foci result in cultures containing 
B  lymphocytes prepared from newborn spleen,  adult lymph node, or macro- 
phage-depleted adult spleen cell suspensions. By incorporating a critical num- 
ber of adherent peritoneal macrophages within a culture underlayer, B-lympho- 
cyte colony formation was markedly augmented; an effect which was mediated 
by the elaboration of one or more diffusible substances of macrophage origin. 
The  magnitude of potentiation of B  lymphocyte colony formation increased 
when the target lymphoid cell suspensions were previously depleted of adherent 
or phagocytic cells,  indicating that  a  macrophage population indigenous to 
adult lymph node or spleen plays an accessory cell role in B-cell activation in 
vitro. 
When the number of macrophages exceeded that required for optimal poten- 
tiation, B-cell clonal proliferation was markedly suppressed. This suppressive 
function of macrophages was largely prevented by incorporating the prostaglan- 
din synthetase inhibitor, indomethacin (27), into the culture underlayers. The 
interpretation of a role for macrophage-derived  prostaglandin in the suppression 1430  B-CELL  REGULATION  BY  MACROPHAGE  FACTORS 
of B-cell  activation  is  consistent  with  our  previous  observations  that  the 
synthetic E-series  prostaglandins  are  efficacious inhibitors  of B-lymphocyte 
clonal  proliferation in  spleen  cell  cultures  (24), and  that  the  mononuclear 
phagocyte is  the principal hemopoietic cell source of PGE  (25, 26). Both B- 
lymphocyte stimulatory and  inhibitory principles  could be  demonstrated in 
macrophage supernates,  the  net  levels  of which were dependent upon  the 
numbers of macrophages permitted to condition medium, and the concentration 
of conditioned medium added to the B-lymphocyte cultures. 
When macrophage influence was optimized by the use of culture underlayers 
containing an ideal concentration of both macrophages and indomethacin, the 
number of proliferating B-lymphocyte colonies was  a  linear function of the 
number  of rigorously macrophage-depleted lymph  node  cells  added  to  the 
cultures. Similar potentiation was observed in such cultures by the addition of 
LPS or intact SRBC,  and it can thus be argued that macrophages may not be 
obligate to B-cell activation by mitogens. In this regard, since the number of 
colonies resulting in cultures containing more than one of these agents was 
equal to or greater than the sum of those in cultures potentiated by any one 
alone, it is possible that different B-cell subpopulations are detected under the 
different conditions. If this is so, they must be closely related since none are 
functional in CBA/N mice (28). In addition to possible direct effects that LPS 
and  SRBC  might  have  on  B  lymphocytes, these  substances  modulate  the 
elaboration  or  regulatory factors  by  macrophages.  In  the  presence  of low 
numbers of macrophages, SRBC facilitated the production and/or release of the 
B-cell stimulating activity. Conversely, when added to high concentrations of 
macrophages, SRBC, and to a greater extent, LPS, promoted the elaboration of 
inhibitory factors. This heightened suppressor activity of macrophages exposed 
to LPS was again largely indomethacin-sensitive and we have found in other 
experiments that LPS is a potent stimulator of PGE production by macrophages.  2 
We have not as yet characterized the macrophage-derived factor(s) which 
augment B-cell  activation and we do not know if it plays a  role in immune 
responsiveness in vivo.  However, since we have been unable to demonstrate 
this  activity in media conditioned by a  variety of other cell types,  it seems 
unlikely that it is merely a nutritional factor. Furthermore, since the addition 
of macrophages or macrophage-conditioned medium does not replace the need 
for 2-ME, these must subserve two entirely different functions in potentiating 
B-cell proliferation. There is certainly precedence in the literature for a role for 
adherent cells or their products in a variety of in vitro immune responses. For 
example,  macrophages provide factors necessary for T-cell activation in  re- 
sponse to mitogens (2) and histocompatibility antigen (4), augment the in vitro 
antibody response of B cells to SRBC  (6), and substitute for a T-helper cell in 
the B  lymphocyte response to T-dependent antigens  (11). Alternatively, the 
macrophage-derived B-cell colony-stimulating factor may be one of the neutral 
proteases released by adherent cells which potentiates in vitro phytohemagglu- 
tinin and purified protein derivative responses (29), or may be similar to the 
factor described by Namba and Hanoaka (30) which is produced by adherent 
spleen cells and a phagocytic cell line and which stimulates the proliferation of 
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an IgM myeloma cell line.  Similarly,  Metcaff (31) described a  factor which 
potentiates the cloning of murine plasmocytoma cells in vitro, and Hamburger 
and Salmon (32) found that conditioned medium of oil-primed murine spleen 
cells is required for colony formation by primary human myeloma cells. 
The capability to document a requirement for macrophages for B-cell activa- 
tion in semisolid culture is in contrast with previously reported observations 
(12-15)  that  T-cell,  but  not  B-cell  responses  in  mitogen-stimulated liquid 
cultures are augmented by the presence of macrophages. Our findings confirm 
that in conventional liquid cultures, macrophage enhancement of Con A, but 
not LPS or agar-mitogen responses, is demonstrable. What then may account 
for  the  different  macrophage  requirements  in  the  two  B-cell  proliferative 
assays? In contrast to conventional liquid cultures, the focal proliferation of B 
cells in semisolid medium occurs under extremely low cell densities (103 cells/ 
ram  ~) in which the cells are separated in three dimensions. In liquid cultures, 
cells settle to the bottom of the culture well and the actual cell densities are 
much greater  (1.45  x  104/mm~). Reduction of cell numbers in liquid cultures 
eightfold (1.8  x  10  ~ cells/mm  2) such that normal but not CBA/N cell mitogen 
responses occur, did not permit a macrophage requirement to be demonstrable. 
It is therefore possible that conventional mitogen-stimulated liquid cultures 
prepared from even the most meticulously purified lymphocyte suspensions 
facilitates the crucial interaction between  lymphocytes  and contaminating 
macrophages, and that this  cell-to-cell  contact must be prevented in order to 
demonstrate a macrophage requirement. Other differences  exist  between the 
liquid  and semisolid  culture  systems. Responses in  liquid  cultures  were assessed 
after  72 h, whereas focal  B-cell  proliferation  in semisolid  medium is optimally 
observed after 6 days of culture. Colony formation is dependent upon 2-ME 
(16),  mitogens native to laboratory grade agar (17)  and serum, whereas B-cell 
activation  by LPS in liquid  cultures is demonstrable in the absence of 2-ME 
and serum (P. W. Kincade, unpublished observations).  B-cell  clonal  expansion 
in soft  agar medium is  probably more fastidious  than short-term liquid  culture 
responses and the semisolid colony assay may be uniquely suited  to studying 
the role  of  accessory  cells  because macrophage-lymphocyte, as well  as lympho- 
cyte-lymphocyte contact  is  prevented. 
It tends to be the rule  that whenever macrophages are found to promote 
some aspect  of  immune function,  they can also  inhibit  that particular  function. 
In cases where both stimulatory and inhibitory  activities  are observed, inhibi- 
tion  is consistently  viewed as the result  of  excess  macrophages (12,  33-37).  The 
interpretation that this  inhibitory  effect  is due to an accumulation of excess 
helper factors  is  conjectural,  since  macrophages may elaborate  separate factors 
with enhancing or suppressive activities.  In our studies  this  is  clearly  the case, 
and the inhibitory activity  has been putatively defined as PGE.  Similarly, 
depressed immune status  may result  from an accentuated inhibitory  role  of  the 
macrophage. This is  indicated  by the recent  reports  of  a suppressor macrophage 
in the peripheral blood of  patients  with multiple myeloma who are unable to 
generate a polyclonal  irnmunoglobulin synthetic  response to  pokeweed mitogen 
(38,  39).  In this  context,  it has been reported by Gailani et al. (40)  that bone 
marrow  from  patients with multiple  myeloma  releases large amounts  of 
prostaglandin during culture;  an observation which is given particular  rele- 1432  B-CELL  REGULATION  BY  MACROPHAGE  FACTORS 
vance in view of our present findings that macrophage-derived prostaglandin 
exerts  a  profound  inhibition  on  B-cell  activation.  Similarly,  the  recently 
described inhibition of human T-cell colony formation by a  dialyzable factor 
from adherent human spleen cells and monocytes (41) may also be a prostaglan- 
din-mediated event, whose pathoclinical correlate may be the marked suppres- 
sion of T-cell proliferation observed in patients with Hodgkin's disease (42) or 
solid tumors (43). Derangements in the otherwise physiologic functions of a 
regulatory cell could then result in accentuated immunopotentiation or signifi- 
cant immunosuppression. 
We have examined the role of accessory cells in B-cell activation by exploiting 
a simple culture system in which humoral regulation of B lymphocytes may be 
selectively studied. This report clearly documents the ability of macrophages to 
either  potentiate or  inhibit  the  clonal  proliferation  of B  cells  in  semisolid 
medium. The dissociation of stimulatory and inhibitory mechanisms, by incor- 
porating an  inhibitor  of prostaglandin synthesis  into  the  two-layer  culture 
system,  suggests  that  each  may  operate  via  separate  macrophage-derived 
factors. 
Summary 
A functional subpopulation of murine B lymphocy~es proliferate in semisolid 
agar culture in the presence of 2-mercaptoethanol to form colonies. The effects 
of diffusible macrophage-derived factors on this focal proliferation was investi- 
gated using a two-layer culture system which prevented macrophage-lympho- 
cyte contact and permitted B-cell  activation to  be  critically  assessed under 
conditions of extremely low cell densities.  Adherent peritoneal macrophages 
incorporated within underlayers of spleen or lymph node cell cultures poten- 
tiated both the number and size of developing B-cell  colonies. These effects 
were  most  striking  when  low  numbers  of spleen  or  lymph  node  cells,  or 
macrophage-depleted lymphoid cell suspensions were used. Thus, macrophage- 
depleted lymph node ceils gave rise to virtually no colonies, but colony-forming 
ability was restored by the presence of an optimal number of macrophages. 
When the number of macrophages exceeded that required for optimal stimula- 
tion, colony formation was suppressed; an effect which was largely prevented 
by indomethacin, an inhibitor of prostaglandin synthesis. Under these condi- 
tions, stimulation and inhibition of B-cell activation by macrophages could be 
dissociated, indicating that each signal is selectively controlled by individual 
molecules elaborated  by  the  macrophage.  With  an  appropriate  number  of 
macrophages required  for  B-cell  activation,  and  sufficient indomethacin to 
inhibit the accumulation of macrophage-derived prostaglandin, B-lymphocyte 
clonal proliferation was a  linear function of the number of B  cells placed in 
culture. In the absence of macrophages, B-cell colony formation was potentiated 
by both lipopolysaccharide and intact sheep erythrocytes through a mechanism 
different from that of the macrophage-derived stimulatory factor. In addition to 
their direct stimulatory effect on B-cell proliferation, lipopolysaccharide and 
sheep  erythrocytes were  each  capable  of modulating the  production and/or 
release of B-cell stimulatory and inhibitory factors by the macrophage. Parallel 
studies of conventional mitogen-stimulated lymphocyte cultures did not show a J.  I.  KURLAND,  P.  W.  KINCADE,  AND  M.  A.  8.  MOORE  1433 
requirement for macrophages and confirm that the semisolid assay is uniquely 
suited to studies on the regulatory role of the macrophage in B-cell activation. 
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